
The company introduces Gut & Protein Optimizer, a probiotic-enzyme formula for protein utilization, and NMN 300 mg, an NAD+ precursor.
In this episode, Lisa C. Buono, principal of client insights at IRI Worldwide, helps Nutritional Outlook understand how consumer buying habits in the dietary supplement space may change once the COVID-19 pandemic improves.






